Objective-Human urotensin-II (UII) is considered the most potent endogenous vasoconstrictor discovered to date, although the precise mechanism activated downstream of its receptor UTS2R in blood vessels remains elusive. The aim of this study was to determine the role of the store operated Ca 21 entry (SOCE) signaling pathway in UII-induced coronary artery vasoconstriction. Methods and Results-We used a combination of isometric tension measurement, Ca 21 imaging, pharmacology, and molecular approaches to study UII-mediated rat coronary artery vasoconstriction and intracellular Ca 21 mobilization in coronary smooth muscle cells. We found that UII promoted dose-dependent vasoconstriction and elicited Ca 21 and Mn 21 influx, which were sensitive to classical SOCE inhibitors. In addition, knockdown of either STIM1 or Orai1 essentially inhibited UII-mediated SOCE and prevented UII but not high-KCL evoked contraction in transfected coronary artery. Moreover, we found that Ca 21 -independent phospholipase A 2  was involved in UII effects and that is colocalized with STIM1 in different submembrane compartments. Importantly, STIM1 but not Orai1 downregulation inhibits significantly independent phospholipase A 2 activation. Furthermore, lysophosphatidylcholine, an independent phospholipase A 2 product, activated Orai1 but not STIM1-dependent contraction and SOCE. Conclusion-Here, we demonstrated that different critical players of SOCE signaling pathway are required for UII-induced vasoconstriction of rat coronary artery. (Arterioscler Thromb Vasc Biol . 2012;32:1325-1332 .)
U rotensin II (UII) is a cyclic undecapeptide that is considered the most potent endogenous vasoconstrictor discovered to date in different mammals. 1, 2 In humans, resistance coronary arteries are extremely sensitive to UII compared to epicardial conduit arteries, implying a more important role for these resistance coronary arteries in regulating blood flow to the heart. 3 UII binds to a Gq-protein coupled receptor, known as orphan receptor GPR14 or urotensin receptor (UTS2R). 4, 5 UTS2R activation results in the stimulation of phospholipase C (PLC) and inositol triphosphate (IP 3 ) production, which triggers the release of Ca 21 from the sarcoplasmic reticulum (SR). 6 UII and UTS2R are highly expressed within the human cardiovasculature (vascular SMC, endothelium, myocardium, etc.) [7] [8] [9] ; and their overexpression has been implicated in a number of cardiovascular diseases, such as arteriosclerosis, heart failure, and hypertension. 9, 10 In rat aorta, UII increases the vascular tone, which was partially inhibited, although not abolished, by the L-type voltage-dependent Ca 21 channels (LTCC) antagonist verapamil. 11 Other reports have suggested a role for RhoA and Rho-kinase, or for PKC and tyrosine kinase signaling pathways in UII-induced rat aorta contraction. 12, 13 However, the signaling pathway of UII is not fully established, especially in small resistance vessels such as coronary arteries.
see accompanying article on page 1066
It is now agreed that agonist-induced vascular SMC contraction is mediated by a rapid Ca 21 release by IP 3 from intracellular stores and a transmembrane Ca 21 influx through LTCC and/or nonvoltage-gated channels such as store-operated Ca 21 channels (SOCC). 14, 15 Recently, we have demonstrated the importance of the store operated Ca 21 entry (SOCE) in agonist induced coronary artery vasoconstriction, and we have confirmed the critical role of Ca 21 -independent phospholipase A 2 (iPLA 2 ) and its product lysophosphatidylcholine (LPC) in SOCE regulation and agonist evoked urotensin-ii signaling Mechanism in rat Coronary artery role of stiM1 and Orai1-dependent store Operated Calcium influx in Vasoconstriction contraction. 16 The discovery of STIM1 as the dynamic sensor of Ca 21 within the endo-sarcoplasmic reticulum (ER/SR), and Orai1 as the pore forming subunit of SOCC, have provided important information into the possible mechanism of SOCE. 17, 18 Decreased luminal Ca 21 activates STIM1 causing their aggregation and translocation to the plasma membrane where STIM1 couples directly to Orai1 allowing Ca 21 entry. 19 In the present study, we aimed to give further insights into the signaling pathway that mediates the effect of UII in coronary artery with special emphasis on SOCE regulated by STIM1, Orai1, and iPLA 2 .
Methods
An expanded Materials and Methods section detailing the protocols and techniques used in this study can be found in the online-only Data Supplement.
Cells and artery Preparation
Isolated rat coronary arteries were dissected from the heart of adult male Wistar rats weighing 250 to 450 g and cells culture were prepared as previously described. 16 Isometric tension was measured in rat coronary arterial rings (2 mm) using a small-vessel myograph (JP Trading, Aarhus, Denmark) connected to a digital recorder (Myodataq-2.01, Myodata-2.02 Multi-Myograph System) as previously described. 16 intracellular Ca 21 Measurement Ca 21 and Mn 21 measurement were carried out in isolated SMC loaded with 2 to 5 mol/L fura-2 am using an imagine system (InCyt Im2, Intracellular Imaging, Imsol, UK) equipped with a light-sensitive CCD camera (Cooke PixelFly, ASI, Eugene, OR) as described previously. 16, 20, 21 
results uii Mediates Vasoconstriction through uii receptors, uts2r, in Coronary artery
First, we examined the effect of UII on coronary artery contraction. Figure 1A shows that the cumulative application of UII produced a concentration-dependent vasoconstriction in endothelium-denuded coronary arterial rings. Maximal contraction was observed when UII was applied at 100 nmol/L concentration and the EC 50 521.21.3 nmol/L comparing to the vasoconstriction induced by 60 mmol/L KCL. To demonstrate the involvement of UTS2R in UII effects in coronary artery, we first confirmed by Western blot the presence of UTS2R in both rat coronary artery and in primary culture of coronary SMC ( Figure 1B inset). Next, we examined the effect of urantide, suggested as the most powerful peptide based antagonist of UTS2R, 22 on vessels contraction and Ca 21 mobilization. As illustrated in Figure 1B , urantide at 100 nmol/L significantly prevented UII (20 nmol/L)-induced contraction, whereas the response to high-KCL was unaffected. Furthermore, the addition of UII (20-50 nmol/L) in isolated coronary SMC evoked an intracellular Ca 21 increase that was significantly inhibited by urantide ( Figure 1C ). UTS2R is functionally linked to Gq11 protein whose activation stimulates PLC, hence the PLC inhibitor U73122 was tested. Figure  1C shows that UII-induced intracellular Ca 21 mobilization was significantly blocked in cells pretreated 10 minutes with U73122 (50 mol/L). Moreover, none of the rings tested in the presence of U73122 showed any significant response to 100 nmol/L UII (data not shown). These data confirm that UII stimulates UTS2R and PLC cascade to induce intracellular Ca 21 increase and coronary vasoconstriction.
role of sOCe in uii induced Vasoconstriction
Next, we determined whether UII activation of PLC/IP 3 signaling cascade would stimulate a functional SOCE pathway in short-term cultured coronary SMC. Figure 2A and 2C shows that UII at 50 nmol/L applied in the absence of extracellular Ca 21 induced transient cytosolic Ca 21 release from SR. The readdition of extracellular Ca 21 evoked Ca 21 influx similar to that typically evoked by passive depletion of SR with TG (2 mol/L, Figure 2B and 2C). SMC treatment with pharmacological inhibitors of SOCE, 23 Gd 31 (5 mol/L), 2APB (50 mol/L), and DES (1 mol/L) 24 significantly blocked UII and TG-evoked Ca 21 influx in coronary SMC. On the other hand, we used the Mn 21 -quench technique to confirm SOCE activation by UII and to exclude the influence of mechanisms that remove Ca 21 from the cytoplasm. 23, 25 Figure 2D -2F shows that UII induced an influx of Mn 21 alike that induced by TG, which was also sensitive to 2APB (50 mol/L), DES (1 mol/L), and Gd 31 (5 mol/L).
We next investigated SOCC implication in UII-evoked coronary vasoconstriction. Figure 3A shows that UII (20 nmol/L) applied in Ca 21 free solution elicited a transient contraction, and the subsequent addition of Ca 21 (2 mmol/L) in presence of nifedipine (0.5 mol/L) led to a sustained contraction that was significantly antagonized either by 2APB (50 mol/L) or by Gd 31 (5 mol/L, mean data in Figure 3A ). Additionally, the contraction induced by Ca 21 restoration in the absence of nifedipine was significantly Figure 2 . Urotensin-II (UII) and thapsigargin stimulate store-operated Ca 21 and Mn 21 influx in primary culture of coronary SMC. A and B, Representative recordings of the changes in intracellular Ca 21 concentration (presented as fura-2 ratio, F 340 /F 380 ) in rat coronary smooth muscle cells (SMC). UII (50 nmol/L) or thapsigargin (TG, 2 mol/L) were applied 3 minutes in the absence of extracellular Ca 21 and then 2 mmol/L Ca 21 was added as indicated. Traces are for SMC treated with UII or thapsigargin (TG), in cells preincubated 3 minutes with gadolinium (1Gd 31 higher than in rings treated with nifedipine (mean data in Figure 3A ). Moreover, as illustrated in Figure 3B -3E, the addition of UII in normal Krebs solution (containing 2 mmol/L Ca 21 ) evoked contraction that was effectively relaxed with Gd 31 (5-10 mol/L), 2APB (50 mol/L), or DES (1 mol/L).
stiM1 and Orai1 involvement in uii evoked Ca 21 entry and Contraction
Once we determined the role of SOCE in UII-mediated contraction, we investigated the participation of STIM1 and Orai1 in UII effects. First, we verified that RNA knockdown of STIM1 and Orai1 specifically reduced the expression level of their mRNA in coronary SMC ( Figure IA Furthermore, to assess the role of STIM1 and Orai1 as determinant proteins responsible for UII-activated Ca 21 entry and the consequent vasoconstriction, we examined UII application in coronary arterial rings transfected with STIM1 or Orai1 siRNA. STIM1 and Orai1 downregulation was effective in transfected rings ( Figure 4C and Figure IIa in the online-only Data Supplement) which inhibited UII-induced contraction, meanwhile high-KCL-activated contractions were not affected compared to the response in rings transfected with scramble RNA ( Figure 4C ). Consistently, Orai1 and STIM1 downregulation also inhibited phenylephrine evoked contraction ( Figure  II in the online-only Data Supplement).
iPLa 2 b involvement in uii effects
Several reports have determined the crucial role of iPLA 2 in SOCE. 26 Here, we explored the potential involvement of iPLA 2 modulation of SOCE in UII actions. Figure 5A shows that SMC treatment with 50 nmol/L UII stimulated iPLA 2 activity, which was abolished in cells preincubated with urantide, UTS2R antagonist. In addition, SMC pretreatment with iPLA 2 inhibitor bromoenol lactone (BEL, 25 mol/L) significantly blocked iPLA 2 activation by UII. Next, we compared the effects of S-BEL and R-BEL, chiral enantiomers of BEL capable to discriminate between iPLA 2 isoforms  and g, respectively. 27, 28 Figure 5A shows that UII-evoked iPLA 2 activation was inhibited in SMC treated with S-BEL (specific to iPLA 2 ) but not with R-BEL (specific to iPLA 2 g). Furthermore, UII-elicited Ca 21 ( Figure  5B ) and Mn 21 influx ( Figure 5C ) were prevented by BEL (25 mol/L) and specifically inhibited by S-BEL (25 mol/L) but not R-BEL (25 mol/L). Interestingly, UII evoked contraction was also significantly relaxed by BEL (25 mol/L) and S-BEL (25 mol/L), but not by R-BEL (25 mol/L) as shown in Figure 5D -5F. These data confirm that UII requires active iPLA 2  to promote Ca 21 entrance and artery contraction.
Afterward, we performed several sets of experiments to examine the role of iPLA 2  stimulation in SMC and vessels lacking STIM1 and Orai1. Figure 6A shows that UII activation of iPLA 2 was attenuated in SMC transfected with siRNA for STIM1 but not by Orai1 knockdown. Next, we used immunofluorescence to elucidate the relationship between endogenous STIM1 and iPLA 2 . Figure 6B and Figures III and IV in the online-only Data Supplement show that in resting cells STIM1 and iPLA 2 are distributed uniformally through cells' compartments. However, cell treatment with 50 nmol/L UII or with 2 mol/L TG resulted in STIM1 redistribution in the subplasma membrane region that was clearly colocalized to iPLA 2 as shown in the magnified picture and graph detail in Figure IV in the online-only Data Supplement. These data indicate that iPLA 2 could colocalize with STIM1 and require at least in part STIM1 to promote UII action.
Orai1 but Not stiM1 downregulation inhibited Lysophosphatidylcholine-induced sOCe and Contractions
The activation of iPLA 2 produce lysophopholipids that are known to activate SOCE. 16, 21, 26 We tested whether LPC could mimic the effects of UII. First, LPC (300 nmol/L) activated 2APB and Gd 31 sensitive Ca 21 influx and coronary artery contraction as shown in Figure V in the online-only Data Supplement. Considering that LPC is a ligand of certain Gq-protein coupled receptor in some cell line, 29 we found that LPC (300 nmol/L) induced Ca 21 influx was not affected by PLC inhibition with U73122 (50 nmol/L, Figure VI in the online-only Data Supplement). Next, in SMC transfected with siRNA STIM1, LPC (300 nmol/L) stimulated practically the same Ca 21 and Mn 21 influx compared to those transfected with scramble siRNA (Figure 6C and 6D) . Interestingly, the disruption of STIM1 in small rings also failed to inhibit LPC-induced contraction as illustrated in Figure 6E . However, LPC mediated Ca 21 and Mn 21 entry in cells, or contractions in vessels transfected with Orai1 siRNA were significantly attenuated ( Figure 6C-6E) , confirming that LPC require Orai1 but not STIM1 to promote SOCE and contraction. Figure 6E also shows that LPC-evoked contractions in transfected rings were effectively antagonized by 2APB. These data indicate that STIM1 are upstream and Orai1 downstream from iPLA 2  stimulation and its product LPC which activates SOCE and contraction in coronary artery. Altogether, our study suggests that UII activation of UTS2R induces a potent vasoconstriction that involves STIM1, iPLA 2 , and Orai1 dependent Ca 21 entry.
discussion
Several reports have agreed on the growing importance of UII action in a variety of diseases such as hypertension, arteriosclerosis, heart failure, diabetes, and so on. 30 Recently, we have shown that UTS2 gene associates with type 2 diabetes mellitus in European population. 31 UII physiological mechanism is still under debate even though it seems similar to other potent vasoactive agonists. It elicits a strong vasoconstriction via mobilization of intracellular Ca 21 as well as through extracellular Ca 21 entry. 5 This study presents the first evidences of the essential role of SOCE in UII-induced vasoconstriction. We have shown that (1) UII was effective at the nanomolar range confirming that it is among the most potent endogenous vasoconstrictors in rat coronary arteries consistent with its effects in other vessels; 5 (2) UII evoked typical SOCE and contractions that were pharmacologically inhibited with low concentration of Gd 31 , 2APB, and DES, the widely used inhibitors of SOCE in different cell types; 23 (3) Silencing of STIM1 or Orai1 drastically blocked UII-stimulated Ca 21 and Mn 21 entry and contraction; (4) iPLA 2  was required for both UII-evoked Ca 21 entry and contraction; (5) UII-mediated iPLA 2  activation required functional STIM1 that was localized in the proximity of iPLA 2 ; and (6) LPC activated Orai1 but not STIM1 dependent SOCE and vasoconstriction.
We have shown that UII requires UTS2R and PLC signaling cascade, and that SOCC are involved in UII-induced coronary contraction, which indicates for the first time the important role of SOCC in UII signaling pathway. LTCC also seems involved in UII-evoked contraction although their inhibition only partially decreased the UII response. Consistently, we have previously shown that SOCC activation involves LTCC stimulation in coronary artery. 16 Other reports have also suggested a role for LTCC, RhoA/ Rho-kinase, PKC, and tyrosine kinase in UII-induced rat aorta contraction. [11] [12] [13] The new advances in SOCE field have identified STIM and Orai proteins as key molecular signaling players in a number of cell types and have determined their interaction to promote SOCE. [17] [18] [19] However, few reports have studied STIM1-and Orai1-mediated SOCE in SMC other than cultured aortic SMC. 32, 33 To our knowledge, the present study is the first to provide evidence for the existence of endogenous STIM1 and Orai1 proteins in rat coronary artery and SMC. We have showed that downregulation of STIM1 and Orai1 prevented UII-induced Ca 21 and Mn 21 entry in the same way as it inhibited SOCE induced by TG. Importantly, RNA silencing of STIM1 and Orai1 in transfected coronary small ring effectively attenuated UII-evoked contraction. In these conditions, similar effects were also observed when phenylephrine, which activates the G-protein/PLC cascade, was tested. Meanwhile, high-KCL stimulated contractions were not affected by Orai1 neither by STIM1 downregulation, indicating the specific effect of the siRNA and the adequate integrity and function of the artery after vessels transfection. A previous study has determined that antibodies against Orai1 and STIM1 partially prevented TG-induced aorta contraction 33 ; although our data are the first to functionally demonstrate that STIM1 and Orai1 are essential for agonist-induced artery contraction. Knockdown of Orai1 in SMC shows a residual Ca 21 entry that could be due to the remaining expression of Orai1 and/or to the store-independent mechanisms such as TRPC channels activated downstream of PLC and positively regulated by IP 3 . 34 STIM1 is regulating an increasing number of ion channels, such as Orai2 and Orai3, 35 LTCC, 36, 37 several TRPC channels, 38 and even transporters. 39 Here, we showed that STIM1 downregulation attenuated iPLA 2  activation. Moreover, on cells stimulation, STIM1 colocalized with iPLA 2  in submembrane compartments indicating that might communicate functionally. Multiple activation models for SOCE have been proposed and mechanisms linking iPLA 2 to SOCE are still under debate, 26, 40 although iPLA 2 seems essential for SOCE activation in SMC and a variety of arteries, 16, 23, 28 as well as in other excitable and nonexcitable cells as reviewed by Bolotina. 26 Here, we found that LPC-mediated SOCE and vasoconstriction were dependent on Orai1 but not on STIM1. These data suggest that STIM1 are upstream and Orai1 downstream, from iPLA 2  activation and its product LPC which might be required as functional transducers after agonist stimulation, from STIM1 in the SR to Orai1 in the plasma membrane. This hypothesis could be explained by the finding from Balla's group who demonstrated the presence of additional molecular components within the STIM1-Orai1 complex. 41 Therefore, we believe that this finding is not incompatible with direct STIM1-Orai1 interactions and may point toward the involvement of auxiliary proteins that might coactivate or intermediate between STIM1-Orai1 interaction as discussed previously. 26, 40 In summary, we have demonstrated that UII induces a potent vasoconstriction of rat coronary artery, which requires UTS2R/PLC signaling cascade, STIM1, iPLA 2 , and Orai1 activation to enhance intracellular Ca 21 and to evoke vessel contraction as proposed in a simplified model in Figure 7 . Our results could have a wide functional relevance for both physiological and pathophysiological function of coronary artery SMC and their regulation by potent vasoconstrictors such as UII. Future SOCC antagonists would be beneficial in the therapeutic control of SMC function during different vascular pathologies. references Figure 7 . Scheme for Urotensin-II (UII) signaling pathway in coronary artery. We propose that UII binding to UTS2R, promotes IP 3 -induced Ca 21 release, depletion of the stores, activation of STIM1, stimulation of independent phospholipase A 2  (iPLA 2 ), and lysophosphatidylcholine (LPC) activation of store-operated Ca 21 channels (SOCC) (Orai1) and then Ca 21 entry. Ca 21 release from the stores and Ca 21 entry through SOCC and L-type voltage-dependent Ca 21 channels (LTCC) trigger UII induced vasoconstriction of coronary artery. Knockdown of STIM1 or Orai1 by siRNA drastically prevents UII-induced Ca 21 entry and further vessel contraction.
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